Warfarin use and stroke, bleeding and mortality risk in patients with end stage renal disease and atrial fibrillation: A systematic review and meta-analysis

Warfarin use and stroke, bleeding and mortality risk in patients with end stage renal disease and atrial fibrillation: A systematic review and meta-analysis

10.1186/s12882-016-0368-6

Saved in:

Bibliographic Details
Main Authors:	Tan, J, Liu, S, Segal, J.B, Alexander, G.C, McAdams-Demarco, M
Other Authors:	DUKE-NUS MEDICAL SCHOOL
Format:	Review
Published:	2020
Subjects:	acetylsalicylic acid apixaban dabigatran placebo rivaroxaban warfarin anticoagulant agent atrial fibrillation bleeding brain ischemia cerebrovascular accident cohort analysis disease association drug use end stage renal disease evidence based medicine gastrointestinal hemorrhage human meta analysis mortality observational study quantitative analysis randomized controlled trial (topic) Review risk assessment risk benefit analysis systematic review thrombosis treatment response complication hemodialysis Hemorrhage Kidney Failure, Chronic Stroke Anticoagulants Atrial Fibrillation Humans Renal Dialysis Warfarin
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/181332
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

Description
Summary:	10.1186/s12882-016-0368-6